Educational only — this site does not provide personalised medical advice. Read the full disclaimer.
Weak

Ketogenic (very low-carb) diet

Last reviewed 25 August 2026 · Evidence-graded review — see Methodology

Cut carbohydrates to roughly 50 grams a day and the body shifts into ketosis, burning fat for fuel instead of glucose. The diet reliably takes weight off quickly and lowers HbA1c in people with type 2 diabetes. What it does not have is long-term evidence in healthy adults, and the observational data on low-carb eating is genuinely mixed. On outcomes people actually care about, it currently earns a weak grade.

Why it grades Weak

Short-term randomised trials are consistent: a classic 2004 trial found a low-carbohydrate ketogenic diet produced more weight loss at six months than a low-fat diet, though the gap narrowed by twelve (Yancy et al., Ann Intern Med 2004). A 2022 systematic review of randomised trials in type 2 diabetes found very-low-carb diets improved HbA1c and triglycerides at six to twelve months, with larger early weight loss. The trouble is what happens after the horizon of a trial ends. The best cohort data we have suggests a U-shaped relationship between carbohydrate intake and mortality: people eating the lowest amounts of carbohydrate, especially when the fat and protein came from animals, had modestly higher all-cause mortality over 25 years than moderate consumers (Seidelmann et al., Lancet Public Health 2018). That is observational, not proof of harm, but it is the opposite of the reassurance a longevity claim needs.

Doing it: If you use it to lose weight or manage diabetes, treat it as a bounded experiment, not a permanent identity: aim for a defined period, keep unsaturated fat sources (olive oil, nuts, fish) ahead of bacon, and if you take glucose-lowering or blood-pressure medication, do the induction under medical supervision. In the long run, no trial shows keto outperforming a Mediterranean-style diet, and the Mediterranean diet has outcome data keto does not.

Who it suits: Adults with obesity or type 2 diabetes who want a structured, quick-start option and can be monitored. Not for anyone with a history of disordered eating, gallstone disease, or kidney disease, and not for people who cannot sustain it long term.

What it costs$–$$$ (protein, fish, nuts and low-carb replacements are pricier than a rice-and-vegetable baseline)

Sources